Christina Catalfano
Physician Assistant · Syracuse, NYNPI 1093062358
Payments from drug & device makers
Across 85 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$185
- GSK$157
- Lilly USA, LLC$145
- Pacira Pharmaceuticals Incorporated$138
- Novo Nordisk$126
- Gilead$119
- plus $897 from 23 others
What the payments were for
- Food & beverage$1,767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $185 |
| GSK | 6 | $157 |
| Lilly USA, LLC | 9 | $145 |
| Pacira Pharmaceuticals Incorporated | 5 | $138 |
| Novo Nordisk | 7 | $126 |
| Gilead | 5 | $119 |
| Smith+Nephew | 4 | $115 |
| Shield Therapeutics Inc | 5 | $95 |
| Merck | 5 | $95 |
| Fidia Pharma USA Inc. | 4 | $71 |
| Amgen | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $58 |
| Exact Sciences | 3 | $53 |
| UCB, Inc. | 1 | $36 |
| Pfizer | 2 | $35 |
| Johnson & Johnson | 1 | $25 |
| Cequr Corporation | 1 | $25 |
| Vericel Corporation | 1 | $25 |
| Grifols USA, LLC | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $12 |
How this compares
$1,767 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 24 | $20,023 |
| EliquisApixaban | 13 | $17,808 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $12,174 |
| FarxigaDapagliflozin Propanediol | 14 | $8,432 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,975 |
| Carbamazepine ErCarbamazepine | 11 | $2,150 |
| Atorvastatin Calcium | 214 | $1,796 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $1,670 |
| Omeprazole | 94 | $802 |
| Levothyroxine Sodium | 83 | $791 |
| Lisinopril | 155 | $768 |
| Losartan Potassium | 95 | $763 |
| Amlodipine Besylate | 117 | $653 |
| Metoprolol Succinate | 45 | $629 |
| Pantoprazole Sodium | 67 | $565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $35 | $17,80813 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $157 | $17,14929 claims |
| AstraZenecaFarxiga | $18 | $8,43214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Syracuse
- Collin MaloneySyracuse$57K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.